Antiplatelet drugs in secondary prevention of stroke: Lessons from recent trials

被引:5
作者
Diener, HC
机构
关键词
D O I
10.1212/WNL.49.5_Suppl_4.S75
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S75 / S81
页数:7
相关论文
共 27 条
[1]   LOW-DOSE VERSUS HIGH-DOSE ASPIRIN IN PREVENTION OF ISCHEMIC STROKE [J].
ADAMS, HP ;
BENDIXEN, BH .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (06) :485-500
[2]   Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia [J].
Algra, A ;
vanGijn, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (02) :197-199
[3]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[4]  
[Anonymous], 1987, Lancet, V2, P1351
[5]  
[Anonymous], 1990, Stroke, V21, P1122
[6]  
[Anonymous], 1988, BRIT MED J, V296, P320
[7]  
[Anonymous], 1988, Br Med J (Clin Res Ed), V296, P316
[8]  
[Anonymous], 1991, Lancet, V338, P1345
[9]   AICLA CONTROLLED TRIAL OF ASPIRIN AND DIPYRIDAMOLE IN THE SECONDARY PREVENTION OF ATHERO-THROMBOTIC CEREBRAL-ISCHEMIA [J].
BOUSSER, MG ;
ESCHWEGE, E ;
HAGUENAU, M ;
LEFAUCCONNIER, JM ;
THIBULT, N ;
TOUBOUL, D ;
TOUBOUL, PJ .
STROKE, 1983, 14 (01) :5-14
[10]  
BOWER S, 1993, CURR OPIN NEUROL NEU, V6, P55